Akebia Therapeutics | AKBA - Selling And Administration Expenses


Akebia Therapeutics reported $23.53M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 160.79M 14.06M Mar/2026
Agios Pharmaceuticals USD 38.46M 4.51M Mar/2026
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alnylam Pharmaceuticals USD 347.92M 65.41M Jun/2026
Amgen USD 1.58B 354M Mar/2026
Ardelyx USD 102.27M 26.35M Mar/2026
Astellas Pharma JPY 234.7B 12.92B Mar/2026
AstraZeneca USD 5.8B 735M Jun/2026
Bayer EUR 3.7B 356M Mar/2026
BioMarin Pharmaceutical USD 258.28M 63.92M Mar/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Exelixis USD 139.6M 16.58M Mar/2026
Fresenius Medical Care EUR 749M 36M Mar/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
Ironwood Pharmaceuticals USD 33.33M 2.78M Dec/2024
J&J USD 6.42B 381M Jun/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Karyopharm Therapeutics USD 9.56M 17.63M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Lexicon Pharmaceuticals USD 3.98M 195K Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Moderna USD 216M 43M Jun/2026
Nektar Therapeutics USD 10.17M 10.17M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 632K 2.33M Jun/2025
Pharma Mar EUR 15.31M 2M Mar/2026
Prothena USD 12.67M 5.02M Mar/2026
PTC Therapeutics USD 73.89M 13.31M Mar/2026
Qiagen NV USD 142.39M 11.49M Mar/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
Sarepta Therapeutics USD 54.03M 51.35M Mar/2026
Sartorius EUR 221.3M 0 Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tectonic Therapeutic USD 6.43M 2.99M Mar/2026
Tilray USD 24.85M 1.7M Sep/2025
Vanda Pharmaceuticals USD 39.28M 1.71M Dec/2024
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026